Cargando…

Clinical characteristics and treatment outcomes in patients with urticarial vasculitis

OBJECTIVE: Urticarial vasculitis (UV) is an uncommon disease clinically presenting with pruritic urticarial plaques of the skin. The disease is classified as normocomplementic and hypocomplementemic types according to their complement levels. We aimed to evaluate demographic characteristics, laborat...

Descripción completa

Detalles Bibliográficos
Autores principales: Serarslan, Gamze, Okyay, Ebru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630719/
https://www.ncbi.nlm.nih.gov/pubmed/34909591
http://dx.doi.org/10.14744/nci.2020.55476
_version_ 1784607418242564096
author Serarslan, Gamze
Okyay, Ebru
author_facet Serarslan, Gamze
Okyay, Ebru
author_sort Serarslan, Gamze
collection PubMed
description OBJECTIVE: Urticarial vasculitis (UV) is an uncommon disease clinically presenting with pruritic urticarial plaques of the skin. The disease is classified as normocomplementic and hypocomplementemic types according to their complement levels. We aimed to evaluate demographic characteristics, laboratory findings, and response to treatment of patients diagnosed as UV in our clinic. METHODS: Between January 2015 and January 2019, the files of the patients were retrospectively reviewed. Demographic data, clinical features, laboratory findings, suspected triggering factors, disease course, treatment modalities, and treatment results of the patients were recorded. RESULTS: A total of 16 patients (nine males [56.25%], seven females [43.75%]) were included in the study.The mean age at diagnosis was 45.2±10.4 years and the duration of the disease was 72.1±62 months. Twelve (75%) patients had angioedema and two (12.5%) patients had residual hyperpigmentation. The most common extracutaneous finding was arthralgia (43.7%). No hypocomplementemia was detected in the patients. The most common abnormal laboratory findings were CRP elevation (37.5%) and ANA positivity (n=4/15, 26.7%). Analgesic and antibiotic drugs use were the most common possible triggering factors for the disease (n=9, 56%). Oral antihistamines, oral corticosteroids, azathioprine, colchicine, dapsone, hydroxychloroquine, doxepin, and omalizumab were among the treatments given to the patients. Complete remission was achieved in three patients. CONCLUSION: Compared with other studies, we found that angioedema was more frequent, postinflammatory hyperpigmentation was lower and long-term treatment was needed to control UV attacks. There are a few studies on UV and we think that more and larger patient groups are needed for standardization of treatment.
format Online
Article
Text
id pubmed-8630719
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-86307192021-12-13 Clinical characteristics and treatment outcomes in patients with urticarial vasculitis Serarslan, Gamze Okyay, Ebru North Clin Istanb Original Article OBJECTIVE: Urticarial vasculitis (UV) is an uncommon disease clinically presenting with pruritic urticarial plaques of the skin. The disease is classified as normocomplementic and hypocomplementemic types according to their complement levels. We aimed to evaluate demographic characteristics, laboratory findings, and response to treatment of patients diagnosed as UV in our clinic. METHODS: Between January 2015 and January 2019, the files of the patients were retrospectively reviewed. Demographic data, clinical features, laboratory findings, suspected triggering factors, disease course, treatment modalities, and treatment results of the patients were recorded. RESULTS: A total of 16 patients (nine males [56.25%], seven females [43.75%]) were included in the study.The mean age at diagnosis was 45.2±10.4 years and the duration of the disease was 72.1±62 months. Twelve (75%) patients had angioedema and two (12.5%) patients had residual hyperpigmentation. The most common extracutaneous finding was arthralgia (43.7%). No hypocomplementemia was detected in the patients. The most common abnormal laboratory findings were CRP elevation (37.5%) and ANA positivity (n=4/15, 26.7%). Analgesic and antibiotic drugs use were the most common possible triggering factors for the disease (n=9, 56%). Oral antihistamines, oral corticosteroids, azathioprine, colchicine, dapsone, hydroxychloroquine, doxepin, and omalizumab were among the treatments given to the patients. Complete remission was achieved in three patients. CONCLUSION: Compared with other studies, we found that angioedema was more frequent, postinflammatory hyperpigmentation was lower and long-term treatment was needed to control UV attacks. There are a few studies on UV and we think that more and larger patient groups are needed for standardization of treatment. Kare Publishing 2020-08-08 /pmc/articles/PMC8630719/ /pubmed/34909591 http://dx.doi.org/10.14744/nci.2020.55476 Text en Copyright: © 2021 by Istanbul Northern Anatolian Association of Public Hospitals https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Original Article
Serarslan, Gamze
Okyay, Ebru
Clinical characteristics and treatment outcomes in patients with urticarial vasculitis
title Clinical characteristics and treatment outcomes in patients with urticarial vasculitis
title_full Clinical characteristics and treatment outcomes in patients with urticarial vasculitis
title_fullStr Clinical characteristics and treatment outcomes in patients with urticarial vasculitis
title_full_unstemmed Clinical characteristics and treatment outcomes in patients with urticarial vasculitis
title_short Clinical characteristics and treatment outcomes in patients with urticarial vasculitis
title_sort clinical characteristics and treatment outcomes in patients with urticarial vasculitis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630719/
https://www.ncbi.nlm.nih.gov/pubmed/34909591
http://dx.doi.org/10.14744/nci.2020.55476
work_keys_str_mv AT serarslangamze clinicalcharacteristicsandtreatmentoutcomesinpatientswithurticarialvasculitis
AT okyayebru clinicalcharacteristicsandtreatmentoutcomesinpatientswithurticarialvasculitis